Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool
Liquid biopsy is emerging as an intriguing tool in clinical disease detection and monitoring. Compared to a standard tissue biopsy, performing a liquid biopsy incurs minimal invasiveness, captures comprehensive disease representation, and can be more sensitive at an early stage. Recent genome-wide l...
Main Authors: | Nicholas Lo, Housheng Hansen He, Sujun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1185013/full |
Similar Items
-
Evaluating liquid biopsies for methylomic profiling of prostate cancer
by: Romina Silva, et al.
Published: (2020-07-01) -
Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01) -
Dose dependent impact of recent alcohol use on genome wide DNA methylation signatures
by: Robert ePhilibert, et al.
Published: (2012-04-01) -
Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01) -
Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer
by: Chad J. Creighton, et al.
Published: (2023-12-01)